Clinical questions. Practical possibilities.
Research & AI
Dr Ghaffari’s work in clinical genetics, genomic diagnostics and the application of AI and digital tools.
Research
Research & clinical interests
- Clinical genetics
- Evaluation of inherited disorders across prenatal, pediatric and adult care.
- Genomic diagnostics
- Application and interpretation of sequencing, copy-number and cytogenetic methods.
- Reproductive genetics & preimplantation testing
- PGT-A, PGT-SR and PGT-M; prenatal screening and diagnosis; infertility and recurrent pregnancy loss.
- Precision medicine
- Connecting molecular findings with clinically meaningful decisions and follow-up.
- AI experience in clinical applications
- Responsible use of artificial intelligence to support clinical workflows, interpretation and medical communication.
- Research & education
- Collaborative studies, laboratory development and communication of genetic knowledge.
- Application development capabilities
- Clinical requirements, workflow design, AI-assisted implementation and acceptance testing for research, education and laboratory applications.
Selected research and screening programs
- Mucopolysaccharidosis (MPS)
- Molecular characterization and diagnostic reassessment, including the IMPRESsion study of 302 patients from 289 families.
- Inherited retinal disease & retinitis pigmentosa (RP)
- Targeted and exome sequencing, molecular diagnosis and genotype–phenotype studies in inherited retinal disorders.
- Newborn screening (NBS)
- Research and implementation experience in screening for inherited metabolic disorders using tandem mass spectrometry (MS/MS).
- Down syndrome & prenatal screening
- Evaluation of prenatal-screening risk software, analysis of screening data and a national program evaluating 500 screening laboratories.
AI-assisted application development & clinical informatics
Clinical requirements, workflow design, AI-assisted implementation and acceptance testing for laboratory and counseling applications.
- Clinical workflow applications
- Configurable workflows, role-based access, structured evidence and controlled reporting.
- Bilingual clinical portals
- Patient intake, document handling, counselor work queues and follow-up workflows.
- Laboratory information systems
- Test catalogs, specimen workflows, quality documentation and reporting; laboratory information systems remain development projects.
National research
Population-based studies in Iran
Dr Ghaffari designed national, population-based studies addressing inherited disorders and screening in the Iranian population.
- Mucopolysaccharidosis (MPS) · 2018
- Study design for molecular characterization and diagnostic reassessment, beginning in 2018.
- Retinitis pigmentosa (RP) · 2009
- Study beginning in 2009, encompassing 3,950 Iranian families.
- Newborn screening (NBS) · 2008
- Project beginning in 2008: expanded newborn screening for inherited metabolic disorders using tandem mass spectrometry.
- Down syndrome screening · 2005
- Screening-data program beginning in 2005, with 101,000 pregnancy records.
Reproductive genetics
Clinical PGT experience
His PGT-A and PGT-SR clinical work encompasses approximately 200 families and more than 1,000 embryos, including NGS-based embryo analysis, copy-number interpretation and genetic counseling.
Diagnostic development
First introductions in Iran
Dr Ghaffari’s work includes introducing the following techniques for the first time in Iran:
- Genomic and molecular diagnostics
- Clinical next-generation sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA), quantitative fluorescent PCR (QF-PCR) and HPV genotyping.
- Prenatal and newborn screening
- First-trimester screening and expanded newborn screening for inherited metabolic disorders using tandem mass spectrometry.
- Fluorescence in situ hybridization (FISH)
- HER2 amplification testing, and FISH-based preimplantation and prenatal diagnosis.
Recent work · 2026
Clinical direction of software development
Clinical direction of AI-assisted development of laboratory information systems and genetic counseling software (2026), intended for CAP-accredited, CLIA-certified laboratories and designed to support HIPAA compliance; workflow design, structured reporting, quality assurance, genomic-analysis automation and medical-content review.